Clinical Trial Update: Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two daunorubicin dose levels and one versus two induction cycles in adult acute myeloid leukemia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Daunorubicin (daunorubicin)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Leukemia, Myelocytic, Acute | Phase 3 | Status: COMPLETED